Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 46

1.

Consensus-based recommendations for the management of juvenile localised scleroderma.

Zulian F, Culpo R, Sperotto F, Anton J, Avcin T, Baildam EM, Boros C, Chaitow J, Constantin T, Kasapcopur O, Knupp Feitosa de Oliveira S, Pilkington CA, Russo R, Toplak N, van Royen A, Saad Magalhães C, Vastert SJ, Wulffraat NM, Foeldvari I.

Ann Rheum Dis. 2019 Aug;78(8):1019-1024. doi: 10.1136/annrheumdis-2018-214697. Epub 2019 Mar 2.

2.

Growth patterns in early juvenile idiopathic arthritis: Results from the Childhood Arthritis Prospective Study (CAPS).

McErlane F, Carrasco R, Kearsley-Fleet L, Baildam EM, Wedderburn LR, Foster HE, Ioannou Y, Chieng SEA, Davidson JE, Thomson W, Hyrich KL.

Semin Arthritis Rheum. 2018 Aug;48(1):53-60. doi: 10.1016/j.semarthrit.2017.11.002. Epub 2017 Nov 7.

3.

Patterns of pain over time among children with juvenile idiopathic arthritis.

Rashid A, Cordingley L, Carrasco R, Foster HE, Baildam EM, Chieng A, Davidson JE, Wedderburn LR, Ioannou Y, McErlane F, Verstappen SMM, Hyrich KL, Thomson W.

Arch Dis Child. 2018 May;103(5):437-443. doi: 10.1136/archdischild-2017-313337. Epub 2017 Nov 25.

4.

The prioritization of symptom beliefs over illness beliefs: The development and validation of the Pain Perception Questionnaire for Young People.

Ghio D, Thomson W, Calam R, Ulph F, Baildam EM, Hyrich K, Cordingley L.

Br J Health Psychol. 2018 Feb;23(1):68-87. doi: 10.1111/bjhp.12275. Epub 2017 Oct 9.

5.

Treatment prescribing patterns in patients with juvenile idiopathic arthritis (JIA): Analysis from the UK Childhood Arthritis Prospective Study (CAPS).

Davies R, Carrasco R, Foster HE, Baildam EM, Chieng SEA, Davidson JE, Ioannou Y, Wedderburn LR, Thomson W, Hyrich KL.

Semin Arthritis Rheum. 2016 Oct;46(2):190-195. doi: 10.1016/j.semarthrit.2016.06.001. Epub 2016 Jun 8.

6.

Trends in paediatric rheumatology referral times and disease activity indices over a ten-year period among children and young people with Juvenile Idiopathic Arthritis: results from the childhood arthritis prospective Study.

McErlane F, Foster HE, Carrasco R, Baildam EM, Chieng SE, Davidson JE, Ioannou Y, Wedderburn LR, Thomson W, Hyrich KL.

Rheumatology (Oxford). 2016 Jul;55(7):1225-34. doi: 10.1093/rheumatology/kew021. Epub 2016 Mar 25.

7.

Co-existence of juvenile-onset systemic lupus erythematosus and juvenile myasthenia gravis.

Sampath S, McCann LJ, McDonagh J, Cleary G, Spinty S, Pain CE, Baildam EM, Beresford MW.

Lupus. 2015 Nov;24(13):1462-3. doi: 10.1177/0961203315591030. Epub 2015 Jun 17. No abstract available.

PMID:
26085593
8.

Characterization of human disease phenotypes associated with mutations in TREX1, RNASEH2A, RNASEH2B, RNASEH2C, SAMHD1, ADAR, and IFIH1.

Crow YJ, Chase DS, Lowenstein Schmidt J, Szynkiewicz M, Forte GM, Gornall HL, Oojageer A, Anderson B, Pizzino A, Helman G, Abdel-Hamid MS, Abdel-Salam GM, Ackroyd S, Aeby A, Agosta G, Albin C, Allon-Shalev S, Arellano M, Ariaudo G, Aswani V, Babul-Hirji R, Baildam EM, Bahi-Buisson N, Bailey KM, Barnerias C, Barth M, Battini R, Beresford MW, Bernard G, Bianchi M, Billette de Villemeur T, Blair EM, Bloom M, Burlina AB, Carpanelli ML, Carvalho DR, Castro-Gago M, Cavallini A, Cereda C, Chandler KE, Chitayat DA, Collins AE, Sierra Corcoles C, Cordeiro NJ, Crichiutti G, Dabydeen L, Dale RC, D'Arrigo S, De Goede CG, De Laet C, De Waele LM, Denzler I, Desguerre I, Devriendt K, Di Rocco M, Fahey MC, Fazzi E, Ferrie CD, Figueiredo A, Gener B, Goizet C, Gowrinathan NR, Gowrishankar K, Hanrahan D, Isidor B, Kara B, Khan N, King MD, Kirk EP, Kumar R, Lagae L, Landrieu P, Lauffer H, Laugel V, La Piana R, Lim MJ, Lin JP, Linnankivi T, Mackay MT, Marom DR, Marques Lourenço C, McKee SA, Moroni I, Morton JE, Moutard ML, Murray K, Nabbout R, Nampoothiri S, Nunez-Enamorado N, Oades PJ, Olivieri I, Ostergaard JR, Pérez-Dueñas B, Prendiville JS, Ramesh V, Rasmussen M, Régal L, Ricci F, Rio M, Rodriguez D, Roubertie A, Salvatici E, Segers KA, Sinha GP, Soler D, Spiegel R, Stödberg TI, Straussberg R, Swoboda KJ, Suri M, Tacke U, Tan TY, te Water Naude J, Wee Teik K, Thomas MM, Till M, Tonduti D, Valente EM, Van Coster RN, van der Knaap MS, Vassallo G, Vijzelaar R, Vogt J, Wallace GB, Wassmer E, Webb HJ, Whitehouse WP, Whitney RN, Zaki MS, Zuberi SM, Livingston JH, Rozenberg F, Lebon P, Vanderver A, Orcesi S, Rice GI.

Am J Med Genet A. 2015 Feb;167A(2):296-312. doi: 10.1002/ajmg.a.36887. Epub 2015 Jan 16.

9.

United Kingdom survey of current management of juvenile localized scleroderma.

Hawley DP, Pain CE, Baildam EM, Murphy R, Taylor AE, Foster HE.

Rheumatology (Oxford). 2014 Oct;53(10):1849-54. doi: 10.1093/rheumatology/keu212. Epub 2014 May 21.

PMID:
24850875
10.

Mucocutaneous manifestations in a UK national cohort of juvenile-onset systemic lupus erythematosus patients.

Chiewchengchol D, Murphy R, Morgan T, Edwards SW, Leone V, Friswell M, Pilkington C, Tullus K, Rangaraj S, McDonagh JE, Gardner-Medwin J, Wilkinson N, Riley P, Tizard J, Armon K, Sinha MD, Ioannou Y, Mann R, Bailey K, Davidson J, Baildam EM, Pain CE, Cleary G, McCann LJ, Beresford MW; UK JSLE Study Group.

Rheumatology (Oxford). 2014 Aug;53(8):1504-12. doi: 10.1093/rheumatology/keu137. Epub 2014 Mar 31.

PMID:
24692572
11.

Gain-of-function mutations in IFIH1 cause a spectrum of human disease phenotypes associated with upregulated type I interferon signaling.

Rice GI, Del Toro Duany Y, Jenkinson EM, Forte GM, Anderson BH, Ariaudo G, Bader-Meunier B, Baildam EM, Battini R, Beresford MW, Casarano M, Chouchane M, Cimaz R, Collins AE, Cordeiro NJ, Dale RC, Davidson JE, De Waele L, Desguerre I, Faivre L, Fazzi E, Isidor B, Lagae L, Latchman AR, Lebon P, Li C, Livingston JH, Lourenço CM, Mancardi MM, Masurel-Paulet A, McInnes IB, Menezes MP, Mignot C, O'Sullivan J, Orcesi S, Picco PP, Riva E, Robinson RA, Rodriguez D, Salvatici E, Scott C, Szybowska M, Tolmie JL, Vanderver A, Vanhulle C, Vieira JP, Webb K, Whitney RN, Williams SG, Wolfe LA, Zuberi SM, Hur S, Crow YJ.

Nat Genet. 2014 May;46(5):503-509. doi: 10.1038/ng.2933. Epub 2014 Mar 30.

12.

Recent developments in disease activity indices and outcome measures for juvenile idiopathic arthritis.

McErlane F, Beresford MW, Baildam EM, Thomson W, Hyrich KL.

Rheumatology (Oxford). 2013 Nov;52(11):1941-51. doi: 10.1093/rheumatology/ket150. Epub 2013 Apr 28. Review.

PMID:
23630368
13.

Validity of a three-variable Juvenile Arthritis Disease Activity Score in children with new-onset juvenile idiopathic arthritis.

McErlane F, Beresford MW, Baildam EM, Chieng SE, Davidson JE, Foster HE, Gardner-Medwin J, Lunt M, Wedderburn LR, Thomson W, Hyrich KL; Childhood Arthritis Prospective Study (CAPS).

Ann Rheum Dis. 2013 Dec;72(12):1983-8. doi: 10.1136/annrheumdis-2012-202031. Epub 2012 Dec 20.

14.

Childrens' and parents' beliefs about childhood onset scleroderma are influenced by child age and physical function impairment.

Ennis H, Herrick AL, Baildam EM, Richards HL.

Rheumatology (Oxford). 2012 Jul;51(7):1331-3. doi: 10.1093/rheumatology/kes071. Epub 2012 Apr 17. No abstract available.

PMID:
22513151
15.

Access to care for children and young people diagnosed with localized scleroderma or juvenile SSc in the UK.

Hawley DP, Baildam EM, Amin TS, Cruikshank MK, Davidson JE, Dixon J, Martin NS, Ohlsson V, Pilkington C, Rangaraj S, Riley P, Sundaramoorthy C, Walsh J, Foster HE.

Rheumatology (Oxford). 2012 Jul;51(7):1235-9. doi: 10.1093/rheumatology/ker521. Epub 2012 Feb 16.

PMID:
22344577
16.

Disease activity, severity, and damage in the UK Juvenile-Onset Systemic Lupus Erythematosus Cohort.

Watson L, Leone V, Pilkington C, Tullus K, Rangaraj S, McDonagh JE, Gardner-Medwin J, Wilkinson N, Riley P, Tizard J, Armon K, Sinha MD, Ioannou Y, Archer N, Bailey K, Davidson J, Baildam EM, Cleary G, McCann LJ, Beresford MW; UK Juvenile-Onset Systemic Lupus Erythematosus Study Group.

Arthritis Rheum. 2012 Jul;64(7):2356-65. doi: 10.1002/art.34410.

17.

Clinical features of childhood localized scleroderma in an incidence cohort.

Herrick AL, Ennis H, Bhushan M, Silman AJ, Baildam EM.

Rheumatology (Oxford). 2011 Oct;50(10):1865-8. doi: 10.1093/rheumatology/ker142. Epub 2011 Jul 5.

PMID:
21729934
18.

Delivery of paediatric rheumatology care in the UK--the projected shortfall.

Foster HE, Harrison MJ, Pain CE, Symmons DP, Baildam EM.

Clin Rheumatol. 2011 May;30(5):679-83. doi: 10.1007/s10067-010-1656-3. Epub 2010 Dec 22.

PMID:
21181219
19.

Influence of childhood scleroderma on physical function and quality of life.

Baildam EM, Ennis H, Foster HE, Shaw L, Chieng AS, Kelly J, Herrick AL, Richards HL.

J Rheumatol. 2011 Jan;38(1):167-73. doi: 10.3899/jrheum.100447. Epub 2010 Nov 1.

PMID:
21041272
20.

Comment on: Developing standards of care for patients with juvenile idiopathic arthritis.

Beresford MW, Cleary AG, Foster HE, Hutchinson E, Baildam EM, Davies K; UK MCRN/Arthritis Research UK Paediatric Rheumatology Clinical Studies Group; British Society of Paediatric and Adolescent Rheumatology.

Rheumatology (Oxford). 2010 Nov;49(11):2227-9. doi: 10.1093/rheumatology/keq215. Epub 2010 Jul 22. No abstract available.

PMID:
20650973
21.

Incidence of childhood linear scleroderma and systemic sclerosis in the UK and Ireland.

Herrick AL, Ennis H, Bhushan M, Silman AJ, Baildam EM.

Arthritis Care Res (Hoboken). 2010 Feb;62(2):213-8. doi: 10.1002/acr.20070.

22.

A randomized comparative trial of generalized vs targeted physiotherapy in the management of childhood hypermobility.

Kemp S, Roberts I, Gamble C, Wilkinson S, Davidson JE, Baildam EM, Cleary AG, McCann LJ, Beresford MW.

Rheumatology (Oxford). 2010 Feb;49(2):315-25. doi: 10.1093/rheumatology/kep362. Epub 2009 Nov 30.

PMID:
19948753
23.

A retrospective clinical analysis of pharmacological modalities used for symptomatic relief of Raynaud's phenomenon in children treated in a UK paediatric rheumatology centre.

Gargh K, Baildam EM, Cleary GA, Beresford MW, McCann LJ.

Rheumatology (Oxford). 2010 Jan;49(1):193-4. doi: 10.1093/rheumatology/kep309. Epub 2009 Oct 1. No abstract available.

PMID:
19797310
24.

New advances in the management of juvenile idiopathic arthritis--2: the era of biologicals.

Beresford MW, Baildam EM.

Arch Dis Child Educ Pract Ed. 2009 Oct;94(5):151-6. doi: 10.1136/adc.2009.170860. Review.

PMID:
19770495
25.

New advances in the management of juvenile idiopathic arthritis--1: non-biological therapy.

Beresford MW, Baildam EM.

Arch Dis Child Educ Pract Ed. 2009 Oct;94(5):144-50. doi: 10.1136/adc.2008.144576. Review.

PMID:
19770494
26.

Chronic recurrent multifocal osteomyelitis mimicked in childhood hypophosphatasia.

Whyte MP, Wenkert D, McAlister WH, Mughal MZ, Freemont AJ, Whitehouse R, Baildam EM, Coburn SP, Ryan LM, Mumm S.

J Bone Miner Res. 2009 Aug;24(8):1493-505. doi: 10.1359/jbmr.090308.

27.

Recurrent hemiplegia associated with cerebral vasculopathy following third trimester maternal herpes zoster infection.

West SL, Newton RW, Baildam EM, Turner AJ, Arkwright PD.

Dev Med Child Neurol. 2006 Dec;48(12):991-3.

28.

Camurati-Engelmann disease--a case report and literature review.

Ramanan AV, Hall MJ, Baildam EM, Mughal Z.

Rheumatology (Oxford). 2005 Aug;44(8):1069-72. Epub 2005 Apr 12. Review. No abstract available.

PMID:
15827032
29.

Treatment approaches to juvenile dermatomyositis.

Zipitis CS, Baildam EM, Ramanan AV.

Expert Opin Pharmacother. 2004 Jul;5(7):1509-15. Review.

PMID:
15212601
30.

Occurrence of Raynaud's phenomenon in children ages 12-15 years: prevalence and association with other common symptoms.

Jones GT, Herrick AL, Woodham SE, Baildam EM, Macfarlane GJ, Silman AJ.

Arthritis Rheum. 2003 Dec;48(12):3518-21.

31.

Cutaneous childhood sarcoidosis--a rare disease refractory to treatment.

Ramanan AV, Denning DW, Baildam EM.

Rheumatology (Oxford). 2003 Dec;42(12):1570-1. No abstract available.

PMID:
14645865
32.

Systemic juvenile idiopathic arthritis, Kikuchi's disease and haemophagocytic lymphohistiocytosis--is there a link? Case report and literature review.

Ramanan AV, Wynn RF, Kelsey A, Baildam EM.

Rheumatology (Oxford). 2003 Apr;42(4):596-8. Review. No abstract available.

PMID:
12649409
33.

Use of methotrexate in juvenile idiopathic arthritis.

Ramanan AV, Whitworth P, Baildam EM.

Arch Dis Child. 2003 Mar;88(3):197-200. Review.

34.

Measuring the nutritional status of children with juvenile idiopathic arthritis using the bioelectrical impedance method.

Lofthouse CM, Azad F, Baildam EM, Akobeng AK.

Rheumatology (Oxford). 2002 Oct;41(10):1172-7.

PMID:
12364639
35.

Kawasaki disease following meningococcal septicaemia.

Ramanan AV, Baildam EM.

Arch Dis Child. 2002 Aug;87(2):170-1. No abstract available.

36.

Macrophage activation syndrome is hemophagocytic lymphohistiocytosis--need for the right terminology.

Ramanan AV, Baildam EM.

J Rheumatol. 2002 May;29(5):1105; author reply 1105. No abstract available.

PMID:
12022335
37.

Acute lethal pancreatitis in childhood systemic lupus erythematosus.

Ramanan AV, Thimmarayappa AD, Baildam EM.

Rheumatology (Oxford). 2002 Apr;41(4):467-9. No abstract available.

PMID:
11961182
38.

Muscle involvement in childhood sarcoidosis and need for muscle biopsy.

Ramanan AV, Thimmarayappa AD, Baildam EM.

Ann Rheum Dis. 2002 Apr;61(4):376-7. No abstract available.

39.

Atrophoderma and juvenile idiopathic arthritis.

Ramanan AV, Baildam EM, Judge MR.

Ann Rheum Dis. 2001 Sep;60(9):900-1. No abstract available.

40.

Attention to infants in the first year.

Baildam EM, Hillier VF, Menon S, Bannister RP, Bamford FN, Moore WM, Ward BS.

Child Care Health Dev. 2000 May;26(3):199-215.

PMID:
10921438
41.

The association between physical function and psychological problems in children with juvenile chronic arthritis.

Baildam EM, Holt PJ, Conway SC, Morton MJ.

Br J Rheumatol. 1995 May;34(5):470-7.

PMID:
7788179
42.

Duration and pattern of crying in the first year of life.

Baildam EM, Hillier VF, Ward BS, Bannister RP, Bamford FN, Moore WM.

Dev Med Child Neurol. 1995 Apr;37(4):345-53.

PMID:
7698525
43.

Bronchocutaneous fistula associated with mechanical ventilation.

Baildam EM, Dady IM, Chiswick ML.

Arch Dis Child. 1993 Nov;69(5 Spec No):525-6. No abstract available.

44.

Transient hyperphosphatasaemia of infancy and failure to thrive.

Baildam EM, Mughal MZ, Dalton M, Lewis MA.

Arch Dis Child. 1993 Oct;69(4):470-1. No abstract available.

45.

Sinus histiocytosis with massive lymphadenopathy (Rosai-Dorfman disease): response to acyclovir.

Baildam EM, Ewing CI, D'Souza SW, Stevens RF.

J R Soc Med. 1992 Mar;85(3):179-80. No abstract available.

46.

Job sharing.

Baildam EM, Ewing CI, Jones R, Cummins M.

Arch Dis Child. 1991 Mar;66(3):282-3. No abstract available.

Supplemental Content

Loading ...
Support Center